4 weeks Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Given Average Rating of “Buy” by AnalystsMarketBeat
Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) have been assigned an average rating of “Buy” from the twelve brokerages that are currently covering the firm, Marketbeat Ratings reports. Ten equities research analysts have rated …
Nasdaq 100 · Pharmaceuticals · Science
X